Hospice News May 15, 2024
A majority of palliative care and hospice clinicians feel unprepared to discuss medical cannabis with their patients.
Researchers from Harvard University surveyed 123 hospice and palliative medicine (HPM) fellows regarding their familiarity with medical cannabis. About 71% indicated that they were not “sufficiently informed” to counsel patients on its use, according to a recent study in the Journal of Pain and Symptom Management.
“Most HPM fellows report formal training in the use of medical cannabis. Over half of trainees reported discussing medical cannabis with patients, but few considered themselves sufficiently informed to make cannabis-related clinical recommendations,” the study authors wrote. “These results suggest both a need for expanded high-quality evidence for medical cannabis...